Lack of consistency still causes problems, especially where there are
rotations of SHO's. We did have one incident where an SHO took a paracetamol
reported in SI units as a negligible amount present because he was used to
seeing results reported in mg/L. This was despite a large treatment graph
being available on the A+E wall
Just to be provocative
Pharmacists do not prescribe medicines in molar units
Medications do not exert their pharmaceutical effects in molar equivalents
That should get everyone going :P)
Cheers
John
> -----Original Message-----
> From: Martin Holland [SMTP:[log in to unmask]]
> Sent: Thursday, November 18, 2004 11:24 AM
> To: [log in to unmask]
> Subject: Re: TDM units
>
> That happened 30 years ago when the UK went SI. :-)
>
> Regards,
>
> Martin.
>
> Dr M R Holland
> Dept Clinical Chemistry
> New Cross Hospital
> Wolverhampton
> UK
>
>
> -----Original Message-----
> From: [log in to unmask] [mailto:[log in to unmask]]
> Sent: 18 November 2004 10:27
> To: [log in to unmask]
> Subject: Re: TDM units
>
>
> What happened to the report that was to guide/tell us as to which
> units we should be using to report drug levels?
>
>
>
> ____________________________________________________________
>
> Dr. Helen Grimes, Dept. of Clinical Biochemistry, UCH, Galway,
> Ireland
>
> -----Original Message-----
> From: Mohammad Al-Jubouri [mailto:[log in to unmask]]
> Sent: 18 November 2004 10:03
> To: [log in to unmask]
> Subject: Re: TDM for anti-psychotic drugs
>
>
> Agreed TDM best practice guidelines are essential for
> laboratories and their users. They must be issued by bodies similar to
> NICE and NSF to be followed by all parties. Indeed best practice guidance
> for all diagnostic tests will be welcomed. The ACB venture publication on
> TDM was excellent but is now out of date.
>
> Mohammad
>
>
> Les Culank <[log in to unmask]> wrote:
>
> Dear Angela,
>
> I don't know if this anecdotal stuff will help at
> all.
>
> Some years ago, after we had stopped offering
> Valproate assays (with
> unanimous endorsement of all our adult & child
> neurologists), the psyche
> folks started to bleat.
>
> I spent some time going through various papers with
> our then Director of
> Psychiatry, and two conclusions became obvious:-
>
> 1. evidence for treating bipolar patients with
> Valproate was first class,
> 2. evidence the assay is clinically helpful was
> sparse to non-existent
>
> Since then, psyche valproates are 1 or 2 per annum,
> with a briefed Junior or
> Consultant happy to discuss each with us first (eg
> ?? zero compliance).
>
> Similarly, for other psyche drug requests I always
> ask to discuss before we
> send it, and the number we end up arranging is
> small.
>
> Of course - this doesn't apply to Li+ (?they
> probably don't do enough?), or
> clozapine which they send off themselves anyway.
>
> Best wishes,
> Les
>
>
>
>
> > From: "Woods Angela (East and North Hertfordshire
> NHS Trust)"
> >
> > Reply-To: "Woods Angela (East and North
> Hertfordshire NHS------ACB discussion List Information-------- This is an
> open discussion list for the academic and clinical community working in
> clinical biochemistry. Please note, archived messages are public and can
> be viewed via the internet. Views expressed are those of the individual
> and they are responsible for all message content.
>
> ACB Web Site http://www.acb.org.uk List Archives
> http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions
> (How to leave etc.) http://www.jiscmail.ac.uk/
>
> The information contained in this email and in any attachments is
> confidential
>
> and is designated solely for the attention and use of the intended
> recipient(s).
>
> If you are not the intended recipient of this email, you should not
> use,
>
> disclose, copy, distribute or retain this message or any part of it.
> If you have
>
> received this in error, please notify me immediately and delete all
> copies of
>
> this email from your computer system(s). This email has been
> processed by
>
> an automated anti-virus system; however it is the responsibility of
> the recipient
>
> to ensure that the message (and attachments) is safe and authorized
> for use
>
> in their own environment.
>
> ------ACB discussion List Information-------- This is an open
> discussion list for the academic and clinical community working in
> clinical biochemistry. Please note, archived messages are public and can
> be viewed via the internet. Views expressed are those of the individual
> and they are responsible for all message content.
>
> ACB Web Site http://www.acb.org.uk List Archives
> http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions
> (How to leave etc.) http://www.jiscmail.ac.uk/
>
> ------ACB discussion List Information-------- This is an open discussion
> list for the academic and clinical community working in clinical
> biochemistry. Please note, archived messages are public and can be viewed
> via the internet. Views expressed are those of the individual and they are
> responsible for all message content.
>
> ACB Web Site http://www.acb.org.uk List Archives
> http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions
> (How to leave etc.) http://www.jiscmail.ac.uk/
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
***************************************************************************
This e-mail is confidential and privileged. If you are not the intended
recipent please accept our apologies; please do not disclose, copy or
distribute information in this e-mail or take any action in reliance on its
contents: to do so is strictly prohibited and may be unlawful. Please
inform us that this message has gone astray before deleting it. Thank you
for your co-operation.
***************************************************************************
***************************************************************************
This e-mail is confidential and privileged. If you are not the intended
recipent please accept our apologies; please do not disclose, copy or
distribute information in this e-mail or take any action in reliance on its
contents: to do so is strictly prohibited and may be unlawful. Please
inform us that this message has gone astray before deleting it. Thank you
for your co-operation.
***************************************************************************
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|